Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.
J Geriatr Cardiol
; 18(7): 534-548, 2021 Jul 28.
Article
in English
| MEDLINE | ID: covidwho-1362749
ABSTRACT
The novel coronavirus disease (COVID-19) has hit the healthcare system worldwide. The risk of severe infection and mortality increases with advancing age, especially in subjects with comorbidities such as cardiovascular disease, hypertension, diabetes, obesity and cancer. Moreover, cardiovascular complications such as myocardial injury, heart failure and thromboembolism are frequently observed in COVID-19 cases, and several biomarkers (troponin, NTproBNP and D-Dimer) have been identified as prognostic indicators of disease severity and worst outcome. Currently, there is no specific therapy against SARS-CoV-2, although many medications are under investigation. The aim of this review will be to explore the intertwined relationship between COVID-19 disease and the cardiovascular system, focusing on elderly population. The available supportive treatments along with the related concerns in elderly patients, due to their comorbidities and polypharmacotherapy, will be explored.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
J Geriatr Cardiol
Year:
2021
Document Type:
Article
Affiliation country:
J.issn.1671-5411.2021.07.001
Similar
MEDLINE
...
LILACS
LIS